How do you cure auditory nerve damage

Hope for patients with nerve damage

Every year around 300,000 people in Europe suffer traumatic nerve injuries. Their treatments can be very tedious and expensive. Damage such as paralysis or sensory disorders often remain permanent. Because so far there are no drugs or procedures that increase the regeneration rate of nerve fibers. That could change now: A team of researchers from the Ruhr University in Bochum has discovered an active ingredient in plants that can significantly increase the regeneration speed of nerve fibers. They now want to test the new active ingredient in the “Parregeron” project on various types of injuries. Your goal: You want to bring a drug onto the market that can help many people affected in the future. The Federal Ministry of Research is funding the project in the measure "Validation of the technological and social innovation potential of scientific research - VIP +".

Plant active ingredient accelerates regeneration

The so-called parthenolide - an ingredient of the feverfew plant - could help many sick people or accident victims in the future. “In our previous studies, we were able to show that the active plant ingredient not only accelerates regeneration after injuries in the sciatic nerve, but also improves the quality. As a result, the restoration of the motor and sensory functions could be shortened considerably, ”explains Dietmar Fischer, head of the chair for cell physiology at the Ruhr University in Bochum.

Active ingredient could also help diabetics

“If the tests show the desired results, we could significantly improve the quality of life for a large number of those affected in the future. In particular, patients who suffer nerve injuries in their legs and arms, for example, and who would normally suffer from permanent paralysis and sensory disorders, could particularly benefit from therapy with parthenolide, ”says Fischer with certainty. In addition, the new active ingredient is also a candidate for the treatment of nerve damage in diabetes or facial paralysis, as nerve regeneration is severely restricted here. “This is a major clinical problem and there are currently no treatment options available,” said Fischer.

The project is currently being funded with 1.28 million euros over three years. The scientists then aim to cooperate with a pharmaceutical company. Starting your own business is also not ruled out.